Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Application of the F(ST) statistics to explore pharmacogenomic diversity in the Brazilian population.

Pharmacogenomics - 1 May 2012

Suarez-Kurtz Guilherme, Pena Sergio D J, Hutz Mara H

Abstract excerpt

BACKGROUND: New drug applications submitted to regulatory agencies in developing countries rarely include data from local clinical trials. We used the F(ST) statistics to explore the pharmacogenomic diversity of the Brazilian population and its potential implications in drug regulatory assessment and decisions. METHODS: The F(ST) analyses were based on data for 44 polymorphisms in 12 pharmacogenes among 1034...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Black People
Share to Brazil
Share to Data Interpretation, Statistical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Approval

Share to Ethnicity

Share to HapMap Project

Share to Pharmacogenetics

Share to White People

Source

Identifiers

PMID: 22594509
DOI: 10.2217/pgs.12.39

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Application of the F(ST) statistics to explore pharmacogenomic diversity in the Brazilian population.PMID 22594509Read ↗

Genetic structure of pharmacogenetic biomarkers in Brazil inferred from a systematic review and population-based cohorts: a RIBEF/EPIGEN-Brazil initiative.Semantic proximity Read ↗

Pharmacogenomic implications of population admixture: Brazil as a model case.Semantic proximity Read ↗

Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians.Semantic proximity Read ↗

Population Diversity in Pharmacogenetics: A Latin American Perspective.Semantic proximity Read ↗

VKORC1 polymorphisms in Brazilians: comparison with the Portuguese and Portuguese-speaking Africans and pharmacogenetic implications.Semantic proximity Read ↗

Polymorphisms of ADME-related genes and their implications for drug safety and efficacy in Amazonian AmerindiansSemantic proximity Read ↗

Pharmacogenomics, ancestry and clinical decision making for global populations.Semantic proximity Read ↗

Global pharmacogenomics: distribution of CYP3A5 polymorphisms and phenotypes in the Brazilian population.Semantic proximity Read ↗

Genetic composition of Brazilian population samples based on a set of twenty-eight ancestry informative SNPs.Semantic proximity Read ↗

Patterns of pharmacogenetic diversity in African populations: role of ancient and recent history.Semantic proximity Read ↗

Disparities in allele frequencies and population differentiation for 101 disease-associated single nucleotide polymorphisms between Puerto Ricans and non-Hispanic whites.Semantic proximity Read ↗

Distribution of ABCB1 polymorphisms among Brazilians: impact of population admixture.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.